PT  - JOURNAL ARTICLE
AU  - Visish M Srinivasan
AU  - Michael George Zaki Ghali
AU  - Jacob Cherian
AU  - Maxim Mokin
AU  - Ajit S Puri
AU  - Ramesh Grandhi
AU  - Stephen R Chen
AU  - Jeremiah N Johnson
AU  - Peter Kan
TI  - Flow diversion for anterior choroidal artery (AChA) aneurysms: a multi-institutional experience
AID  - 10.1136/neurintsurg-2017-013466
DP  - 2018 Jul 01
TA  - Journal of NeuroInterventional Surgery
PG  - 634--637
VI  - 10
IP  - 7
4099  - http://jnis.bmj.com/content/10/7/634.short
4100  - http://jnis.bmj.com/content/10/7/634.full
SO  - J NeuroIntervent Surg2018 Jul 01; 10
AB  - Background Anterior choroidal artery (AChA) aneurysms represent a small subset of cerebral aneurysms. The Pipeline Embolization Device (PED) has been successfully applied to various aneurysms of the supraclinoid internal carotid artery (ICA). The treatment of these aneurysms requires special attention due to the eloquent territory supplied by the AChA. We report the largest and first dedicated series of flow diversion treatment of AChA aneurysms.Methods Four institutional neurointerventional databases were reviewed for cases of intracranial aneurysms treated with PED. Patient and aneurysm data as well as angiographic imaging were reviewed for all cases of AChA aneurysms treated with PED. AChA aneurysms were defined as aneurysms distal to the AChA and proximal to the ICA terminus, with or without the incorporation of the AChA.Results Eighteen AChA aneurysms were treated during the study period. All aneurysms were successfully treated with a mean follow-up of 19.1 months. The large majority of aneurysms (15/18, 83.3%) were completely obliterated. No patients suffered from intra- or post-procedural complications. A1 stenosis was a common occurrence, seen in 10 of 16 (62.5%) covered anterior cerebral arteries (ACAs), although all were asymptomatic. All AChAs remained patent at last follow-up.Conclusions The PED can be used successfully in AChA aneurysms with a good safety and efficacy profile. All AChAs remained patent. Collateral flow networks, especially for the ACA, affect long-term branch vessel patency. Treatment with PED for AChA aneurysms appears to be a reasonable option to consider and should be evaluated in a larger cohort.